McPherson's (CHIA:MCP) - Stock Price, News & Analysis

MCP Stock Overview

McPherson's Limited provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally.

About the company

MCP fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	0/6
Financial Health	6/6
Dividends	2/6

Rewards

Trading at 58.3% below our estimate of its fair value

Earnings are forecast to grow 69.5% per year

Risk Analysis

Dividend of 6% is not well covered by earnings

Does not have a meaningful market cap (A$72M)

McPherson's Limited Competitors

Biome Australia

ASX:BIO

AU$68.1m

BWX

ASX:BWX

AU$40.0m

Star Combo Pharma

ASX:S66

AU$16.2m

Bioxyne

ASX:BXN

AU$14.3m

Price History & Performance

Summary of all time highs, changes and price drops for McPherson's
Historical stock prices
Current Share Price	AU$0.49
52 Week High	AU$0.66
52 Week Low	AU$0.37
Beta	0.55
1 Month Change	-7.48%
3 Month Change	-16.10%
1 Year Change	-14.66%
3 Year Change	-67.65%
5 Year Change	-58.40%
Change since IPO	-54.59%

Recent updates

Shareholder Returns

	MCP	AU Personal Products	AU Market
7D	-2.9%	-10.4%	0.9%
1Y	-14.7%	-15.6%	5.7%

Return vs Industry: MCP matched the Australian Personal Products industry which returned -15.6% over the past year.

Return vs Market: MCP underperformed the Australian Market which returned 5.7% over the past year.

Price Volatility

Is MCP's price volatile compared to industry and market?
MCP volatility
MCP Average Weekly Movement	5.7%
Personal Products Industry Average Movement	5.4%
Market Average Movement	8.9%
10% most volatile stocks in AU Market	17.5%
10% least volatile stocks in AU Market	3.5%

Stable Share Price: MCP's share price has been volatile over the past 3 months.

Volatility Over Time: MCP's weekly volatility (6%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1860	n/a	Brett Charlton	www.mcphersons.com.au

McPherson's Limited provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally. It offers beauty care, hair care, skin care, and personal care items, including facial wipes, cotton pads, and foot comfort products; and vitamins and supplements, as well as various kitchen essentials, such as baking papers, cling wraps, and aluminium foils. The company sells its products primarily under the owned brands, including Dr. LeWinn’s, A’kin, Manicare, Lady Jayne, Swisspers, Multix, Fusion Health, Oriental Botanicals, Moosehead, and Maseur.

McPherson's Limited Fundamentals Summary

How do McPherson's's earnings and revenue compare to its market cap?
MCP fundamental statistics
Market cap	AU$71.97m
Earnings (TTM)	-AU$3.56m
Revenue (TTM)	AU$201.69m

0.4x

P/S Ratio

-20.2x

P/E Ratio

Is MCP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MCP income statement (TTM)
Revenue	AU$201.69m
Cost of Revenue	AU$100.55m
Gross Profit	AU$101.14m
Other Expenses	AU$104.70m
Earnings	-AU$3.56m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.025
Gross Margin	50.15%
Net Profit Margin	-1.77%
Debt/Equity Ratio	12.8%

How did MCP perform over the long term?

See historical performance and comparison

Dividends

6.0%

Current Dividend Yield

-147%

Payout Ratio

MCP Stock Overview

Rewards

Risk Analysis

McPherson's Limited Competitors

ASX:BIO

AU$68.1m

ASX:BWX

AU$40.0m

ASX:S66

AU$16.2m

ASX:BXN

AU$14.3m

Price History & Performance

Recent News & Updates

First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023)

Upcoming dividend of AU$0.02 per share

McPherson's Limited Announces Executive Changes

McPherson's Limited, Annual General Meeting, Nov 28, 2023

Upcoming dividend of AU$0.01 per share at 4.0% yield

McPherson's Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended June 30, 2023, Payable on September 22, 2023

Recent updates

First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023)

Upcoming dividend of AU$0.02 per share

McPherson's Limited Announces Executive Changes

McPherson's Limited, Annual General Meeting, Nov 28, 2023

Upcoming dividend of AU$0.01 per share at 4.0% yield

McPherson's Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended June 30, 2023, Payable on September 22, 2023

Full year 2023 earnings released: AU$0.035 loss per share (vs AU$0.003 profit in FY 2022)

McPherson's Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Now 20% undervalued after recent price drop

Less than half of directors are independent

McPherson’s Limited Appoints Brett Charlton as Chief Executive Officer, Effective 1 August 2023

Now 22% undervalued after recent price drop

Mcpherson's Limited Announces Resignation of Grant Peck as Chief Executive Officer, Effective 31 May 2023

First half 2023 earnings released: EPS: AU$0.001 (vs AU$0.017 loss in 1H 2022)

Now 23% undervalued after recent price drop

McPherson's Limited Appoints Linda Gough as Company Secretary

McPherson's Limited to Report First Half, 2023 Results on Feb 28, 2023

McPherson's Limited Announces Resignation of Geoffrey Pearce as Director, Effective November 22, 2022

McPherson's Limited, Annual General Meeting, Nov 22, 2022

Upcoming dividend of AU$0.02 per share

Full year 2022 earnings released: EPS: AU$0.003 (vs AU$0.042 loss in FY 2021)

McPherson's Limited Declares Fully Franked Final Dividend for the Year 2022, Payable on 23 September 2022

McPherson's Limited to Report Fiscal Year 2022 Results on Aug 25, 2022

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Mcpherson's Limited Announces Board Changes

McPherson's Limited Announces Changes to Its Board

McPherson's Limited to Report First Half, 2022 Results on Feb 23, 2022

Arrotex Pharmaceuticals Pty Limited cancelled the acquisition of McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others.

Arrotex Pharmaceuticals Pty Limited made a Non-binding Indicative Offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million.

McPherson's Limited Provides Earnings Guidance for the Full Year 2021

McPherson's Limited Not Providing Earnings Guidance Due to COVID-19

McPherson's Limited Appoints Ari Mervis as Independent, Non-Executive Director to the Board

McPherson's Limited to Report First Half, 2021 Results on Feb 17, 2021

Investor sentiment improved over the past week

McPherson's CEO Change

New 90-day low: AU$1.15

Market pulls back on stock over the past week

New 90-day low: AU$2.11

McPherson's Limited (ASX:MCP) entered into an agreement to acquire Global Therapeutics Pty Ltd from Blackmores Limited (ASX:BKL) for an enterprise value of AUD 27 million.

New 90-day low: AU$2.65

Independent Non-Executive Director recently bought AU$133k worth of stock

New 90-day high - AU$3.15

Full year earnings released - EPS AU$0.057

McPherson's Limited to Report Fiscal Year 2020 Results on Aug 19, 2020

Shareholder Returns

Price Volatility

About the Company

McPherson's Limited Fundamentals Summary

0.4x

-20.2x

Earnings & Revenue

Dividends

6.0%

-147%